Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-31

FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam submitted by Sandoz Inc, related to a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)